Saturday lunchtime #blooducation tweetorial, inspired by someone who came to see me recently. Let's talk Rh null! (NB written by a clinician, for clinicians…scientists please do chip in!)
The Rh protein comprise Rh D C c E and e. “d” does not exist but is used to denote the absence of D. The C/c and E/e proteins are encoded by the RHCE gene and thus inherited together. Rh associated glycoprotein (RhAG) is required for expression of D and CE.
C/c and E/e are antithetical. Antithetical means a pair of antigens that are coded by different alleles of a single gene It does NOT mean that only one is ever carried on a single RBC.
The Rh null phenotype occurs when neither D, C/e or E/e antigens are expressed. Causes include deletions or mutations of the RhAG gene. Red cells also lack LW and Fy5 and show weak expression of S, s, and U antigens
Patients who are Rh null may make anti-RhAG (following stimulation). This is an antibody to a high frequency antigen (HFA). High frequency (or public) antigens are strictly those occurring on the red cells of >90% of the population, but most are >99%.
Finding blood for these patients is tricky- only donors with Rh null themselves will lack the RhAG protein.
The Rh null phenotype is a red cell membrane disorder, hence patients commonly have a chronic low grade haemolytic anaemia with stomatocytes and spherocytes. I say ‘commonly’, but the phenotype is so rare it has not been well studied! <1 in 6 million people are thought to have it
Patients with Rh null do not make good donors! If no alloantibodies are present, patients can be transfused with ABO and kell matched blood.
If they have antibodies to some of the Rh antigens then give antigen negative blood as far as possible...
...If this isn’t possible (e.g. anti E and anti e) use “least incompatible” ABO and kell matched blood, neg for any other antigens the patient has antibodies to, and consider using IVIg and methylprednisolone.
And of course, speak with your @NHSBT consultant! Blood may need to be sourced from the national frozen blood bank, from the rare donor panel or even internationally.
@NHSBT As an aside, #haemSpRs may be interested to note that a standard group and screen will not identify patients who are Rh null, until they develop antibodies, or unless there is reason to undertake a full Rh phenotype!
I had a personal request to do a tweetorial for the #haemSpRs on haemovigilance. Here goes. A #blooducation 🧵
Haemovigilance is a systematic surveillance of adverse reactions and adverse events related to transfusion’ with the aim of improving transfusion safety. transfusionguidelines.org/transfusion-ha…
We are very lucky in the UK to have @SHOTHV1, one of the first in the world to collate adverse events relating to transfusion - since the 1990s.
This morning I met with the chair and vice chair of the Midlands Regional Transfusion Committee, the Midlands Patient Blood Management Practitioner and the Customer Services Manager. What are their roles and what does the RTC do?
A #blooducation 🧵
RTCs serve to bring together Hospital Transfusion Committees to discuss best practice, implement new guidance and provide educational resources and events. They are run by clinicians and scientists working in hospitals, supported by @NHSBT.
Teaching our incoming haematology doctors today about transfusion in haematology patients. So who needs irradiated blood and why? A #blooducation🧵
All blood in the UK is leucocyte reduced (except granulocytes, but that’s another story). Despite this, a unit of red cells or platelets can have around a million residual white cells, mostly lymphocytes.
Every doctor starting in a new trust does transfusion training as part of their mandatory training. But why?
50ml ABO incompatible blood can kill a patient. ABO antibodies are naturally occurring (“everyone” has them) and they are IgM; they can activate complement and cause *immediate* intravascular haemolysis, causing release of free haem, endothelial activation, renal failure and DIC.
In most hospitals, blood banks require 2 samples (one may be historic) before releasing group specific (non-O) blood for a patient. This is to increase the chances of identifying a *wrong blood in tube* (pt whose blood's in the tube is not the pt whose details are on the outside)
It can be difficult to know where to start with transfusion – you can’t go on a ward round to find patients. BUT you do start with lab induction and your helpful #BMSes will show you around.
Excellent session on emergency paediatric transfusion #AABB20. Cyril Jacquot talking on pre hospital transfusion and summarising the literature.
28 day mortality following haemorrhage is higher in children than adults (unpublished data and substudies from PROPPR and PROMMTT)
Observational studies of large numbers of patients but with only very small numbers of paediatric patients suggest that pre hospital blood is not associated with an excess of transfusion reactions and in some studies is thought to have improved survival.
Whole blood, group O, high titre neg, used in paediatrics in Pittsburgh appears to be safe with no haemolysin-mediated haemoylsis in non group O patients (Leeper et al JAMA Pediatrics 2018) ncbi.nlm.nih.gov/pmc/articles/P…